top of page
News
Disturbing Picture Of Lilly, Zyprexa Promotion May Cost Them Over $1 Billion In Fines
February 1, 2008
Share to:
Eli Lilly and federal prosecutors are discussing a possible settlement of both civil and criminal investigations that will amount to more than $1 billion in payments to federal and state governments. Lilly has been accused of breaking federal laws by "off-label marketing" its psychotherapeutic drug, Zyprexa, for uses not approved by the Food and Drug Admistration.
<a href="http://www.nytimes.com/2008/01/31/business/31drug.html?scp=3&sq=lilly&st=nyt">http://www.nytimes.com/2008/01/31/business/31drug.html?scp=3&sq=lilly&st=nyt</a>
Contact
bottom of page